Today shares of Ebola drug maker Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) are getting slammed by more than 5%. There is news out that recent Ebola cases are going to be treated with a rivals's drug and not Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) product. This decline comes just one day after the stock of Tekmira was taken down by nearly 20%. This has become a popular stock among traders and investors looking to make a fast buck. I am looking to the charts and a great entry level I see to buy this names is right around $21. This is a solid level because there is previous consolidation there and also a gap fill. If you are looking to make money on Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) then have the $21 on your watch list.
If you only read one email again, make sure it comes from the Elite Round Table. Our FREE market emails contain information that can actually make you money. Ask yourself, what email have you read that can do that? Answer = none. Join our list here.